Clinical trial
SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
NCT00002651 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00002651 |
|---|---|
| Title | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer |
| Official title | Intermittent Androgen Deprivation in Patients With Stage D2 Prostate Cancer, Phase III |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH NCIC Clinical Trials Group Cancer and Leukemia Group B Eastern Cooperative Oncology Group European Organisation for Research and Treatment of Cancer - EORTC |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Other |
| Interventions | bicalutamide, goserelin acetate, clinical observation |
| Enrollment | 3,040 |
| Start date | May 1, 1995 |
| Primary completion | Jun 1, 2013 |
| Completion | Jun 1, 2013 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 17, 2017 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: